Receptor de cannabinoides

Pregnenolone is an endogenous steroid hormone synthesized from cholesterol, used in the treatment of Alzheimer's …

6-Iodopravadoline is an antagonist of CB2 (Ki: 31.2 nM). And it shows 165-fold selectivity more …

Anandamide, an immune modulator, acts via not only cannabinoid receptors (CB1 and CB2) but also …

VCE-004.8 is a specific dual agonist of PPARγ and CB2 receptor with potent anti-inflammatory activity. …

CB1 antagonist 2 is caimabinoid 1 (CB1) antagonist extracted from patent WO2016184310A1, compound 3. Which …

Rimonabant hydrochloride is a cannabinoid receptor antagonist, binding selectively to central cannabinoid receptors (CB1) with …

Virodhamine, an endocannabinoid, is an antagonist of CB1 receptor and an agonist of CB2 receptor. …

6-Bromopravadoline (WIN 54461) is an antagonist of CB1. 6-Bromopravadoline acts as an inhibitor of the …

SR144528 is an antagonist of the CB2 receptor (Ki = 0.6 nM) and inhibits microsomal …

Pravadoline is a cannabinoid receptor agonist. Pravadoline inhibited the PGs synthesis in mouse brain and …

CB2R/FAAH modulator-2 (compound 26) is a dual modulator targeting at CB2R and FAAH. CB2R/FAAH modulator-2 …

CB2 receptor agonist 2 is a potent and selective agonist for the CB2 (cannabinoid type …

CB2R/FAAH modulator-1, a cannabinoid type 2 receptor (CB2R) agonist, is also a fatty acid amide …

ML192 is a selective GPR55 ligand antagonist. ML192 is an inhibitor that inhibits β-arrestin transport, …

CB2R/FAAH modulator-3 (compound 27) is a modulator targeting at CB2R and FAAH. CB2R/FAAH modulator-3 acts …

Dehydroabiethylamine is an inducer of hepatic CYP2B activity. Dehydroabiethylamine inhibits pyruvate dehydrogenase kinases (PDKs) and …

Olorinab (APD 371) is a highly potent, selective and fully efficacious cannabinoid receptor type 2 …

CB2 modulator 1 is a potent CB2 modulator. It can be used for the research …

AZD1940 is a high affinity CB(1)/CB(2) receptor agonist of the cannabinoid with oral activity. Application …

CB1 inverse agonist 1 is an orally active and selective CB1 agonist. The IC50s for …

NESS 0327 is a high selectivity antagonist of the cannabinoid CB1 receptor. NESS 0327 is …

OMDM-6 is a dual agonist of TRPV1(EC50 = 75 nM) and CB1 (Ki = 3.2 …

Tetrahydromagnolol can activate cannabinoid (CB) receptors.

ML-193 is a potent and selective GPR55 antagonist( IC50 : 221 nM). It shows more …

Cannabichromene is a major non-psychotropic phytocannabinoid that inhibits endocannabinoid inactivation and activates the transient receptor …

Cannabigerol is a high affinity α±2-adrenergic receptor agonist, moderate affinity 5-HT1A receptor antagonist, and low …

SLV319 has been used in trials studying the treatment of Obesity and Obesity and Type …

2,3-Butanediol is a butanediol derived from the bioconversion of natural resources which has great potential …

PSNCBAM-1 is a CB1 receptor negative allosteric modulator (EC50 = 0.1 μM) with hypophagic effects …

Pregnenolone acetate is a powerful neurosteroid, the main precursor of various steroid hormones including steroid …

JD-5037 is a novel, peripherally restricted CB1R antagonist with an IC50 of 1.5 nM.

Otenabant hydrochloride (CP-945598) is a competitive, high affinity, selective antagonist of the CB1 receptor (Ki: …

CB1-IN-1 is a peripherally restricted CB1R antagonist, for CB1R and CB2R with Ki of 0.3 …

A-836339 acts as a potent cannabinoid receptor full agonist which has a higher affinity for …

LY2828360 is a cannabinoid (CB) receptor 2 agonist (Ki = 40.3 nM). It selectively activates …

Otenabant has been investigated for the treatment of Obesity.

Linoleoyl Ethanolamide is an endocannabinoid agent. It acts by binding to TRPV1 increasing ERK phosphorylation …

AM 281, a cannabinoid antagonist, reduces neurologic dysfunction and mortality rate after cecal ligation and …

1. Yangonin is a novel CB receptor ligand, it exhibits affinity for the human recombinant …

AM-2232 is a potent and unselective agonist of the cannabinoid receptors.

N-Oleoyl glycine, a lipoamino acid, was able to promote 3T3-L1 adipogenesis through the activation of …

RTICBM-189 is Brain Penetrant and Attenuates Reinstatement of Cocaine-Seeking Behavior.

ML-184 is a potent synthetic agonist of GPR55 with EC50 of 0.26 μM.

AM251 is a effective CB1 receptor antagonist (IC50/Ki: 8 /7.49 nM) that displays 306-fold selectivity …

Olivetol (5-pentylresorcinol, 5-pentyl-1,3-benzenediol) is an organic compound found in certain species of lichen; it is …

Hemopressin (human, mouse) acetate is a nonapeptide derived from the α1-chain of hemoglobin, is originally …

PSB-SB-487 is antagonist of GPR55.

BML-190 is a specific CB2 receptor inverse agonist (Ki: 435 nM), with 50-fold selectivity over …

CID16020046 is a selective GPR55 antagonist, inhibiting GPR55 constitutive activity with IC50 of 0.15 μM …

GW 405833 is an agonist of cannabinoid-2 (CB(2)) receptor-selective

Voacamine is an indole alkaloid. Voacamine exhibits potent cannabinoid CB1 receptor antagonistic activity. Voacamine also …

Bay 59-3074 is a CB1/CB2 receptor partial agonist (Ki: 48.3/45.5 nM). In rat models of …

COR659 is a 2-acylaminothiophene derivative able to suppress alcohol and chocolate self-administration in rats, likely …

Hemopressin (rat) acetate is a nonapeptide derived from the α1-chain of hemoglobin, is originally isolated …

AM-1241 is a selective cannabinoid CB2 receptor agonist with Ki of 3.4 nM, exhibits 82-fold …

Tetrahydrocannabivarin is a neutral cannabis receptor subtype (CB1) receptor antagonist, it can increases neural responding …

Org 27569, an allosteric modulator of cannabinoid CB1 receptor, can induce a CB1 receptor state …

RVD-Hpα acetate is the N-terminally extended form of human hemopressin that acts as a selective …

OMDM-5 is a potent vanilloid receptor type 1 (TRPV1, EC50 = 75 nM) agonist, showing …

β-Caryophyllene acts as an CB2 receptor agonist.

GW842166X is a potent and highly selective agonist of cannabinoid receptor CB2 receptor with EC50 …

TM38837 is an antagonist of cannabinoid receptor type 1 (CB1), with potential for the treatment …